MarkPirnerMD

Internal Medicine • Newtown, CT

Physician

Join to view full profile

Are you Dr. Pirner?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 29 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1 Stony Brook Rd
Newtown, CT 06470
Phone+1 475-323-7210
Is this information wrong?

Summary

Dr. Mark Pirner, MD is an internist in Newtown, Connecticut. He is currently licensed to practice medicine in Connecticut, Illinois, and Wisconsin.

Education & Training

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000
Duke University HospitalResidency, Internal Medicine, 1996 - 1998
University of Minnesota Medical SchoolClass of 1996

Certifications & Licensure

CT State Medical License 2014 - 2025
IL State Medical License 2002 - 2017
WI State Medical License 2000 - 2003
NC State Medical License 1998 - 2000

Clinical Trials

A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution Start of enrollment: 2021 Feb 16
Completed
Phase 1

Publications & Presentations

PubMed

42 citations
Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1.
J.L. McKeeby, Xiaoming Li, Zhengping Zhuang, Alexander O. Vortmeyer, Steve Huang, Mark Pirner, Monica C. Skarulis, Laura James-Newton, Stephen J. Marx, Irina A. Lubensky> ;The American Journal of Pathology. 2001 Sep 1

Press Mentions

In a First, FDA Approves Drug Meant to Mitigate Symptoms of Opioid WithdrawalMay 16th, 2018
LUCEMYRA, First Drug for Opioid Withdrawal Symptoms, Receives FDA RecommendationApril 4th, 2018